Receiving congratulations, it completes the world's first trillion-dollar market value pharmaceutical company.

On the 21st local time, the stock price of the American pharmaceutical giant Eli Lilly closed up nearly 1.6%, with a market value exceeding $1 trillion, making it the first pharmaceutical company in the world to reach a market value of over a trillion dollars. Since the beginning of this year, Eli Lilly's stock price has risen by more than 35%. Earlier this month, US President Trump announced that Eli Lilly and Danish pharmaceutical company Novo Nordisk will significantly lower the prices of weight loss drugs in the US market in exchange for these drugs being included in the federal Medicare coverage. Analysts suggest that the pricing agreement with the White House may temporarily lower revenues, but will significantly improve drug accessibility, potentially turning up to 40 million Americans into potential users of obesity treatment medications. Wall Street estimates that by 2030, the weight loss drug market will reach $150 billion, equivalent to 1.1 trillion Chinese yuan.